Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and in vivo experimental validation

• 主要な著者: Sisi Lei (著者), Shuai Zhao (著者), Xiaoyan Huang (著者), Yuchao Feng (著者), Zhishang Li (著者), Li Chen (著者), Peiying Huang (著者), Hansu Guan (著者), Haobo Zhang (著者), Qihua Wu (著者), Bojun Chen (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common metabolic disease and is intertwined with cardiovascular disorders and diabetes. Chaihu Shugan powder (CSP) is a traditional Chinese medicine with a significant therapeutic effect on metabolic diseases, such as NAFLD. However, i...